Scancell taps into NHS matchmaking service for cancer trial

Scancell taps into NHS matchmaking service for cancer trial

Scancell is using a new service launched by the NHS to pair patients with suitable clinical trials in a phase 2 trial of its melanoma cancer vaccine.

NHS England Begins Pioneering Trial for Skin Cancer Vaccine

NHS England's SCOPE trial offers hope for a skin cancer vaccine, targeting advanced patients for research and treatment development.

The company's share price has doubled in a year.

SGX301 Shows Rapid and Durable Responses in Early-Stage CTCL

SGX301 has shown rapid and sustained benefit in early cutaneous T-cell lymphoma in an investigator-initiated study, with good safety.

Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial

Additional melanoma patients will have access to Scancell’s DNA vaccine as part of an ongoing clinical trial.The post Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial appeared first on Clinical Trials Arena.

Scancell shares up 6% after NHS partnership for fast-track cancer vaccine trial - Pharmaceutical Technology

Additional melanoma patients will have access to Scancell’s DNA vaccine as part of an ongoing clinical trial.